SB 244 requires all health insurance plans sold in Montana to cover behavioral health screenings and assessments at no cost to the insured. This applies to state employee health plans, disability insurance, health maintenance organizations (HMOs), and self-funded workplace plans. Screenings must use standardized, evidence-based tools, but are optional - insured individuals must actively request them. The bill amends Montana insurance codes to include these coverage requirements, ensuring people can access mental health screenings without out-of-pocket costs when they choose to participate.
SB 394 would have expanded Montana's workers' compensation system to cover posttraumatic stress disorder (PTSD) for eligible first responders. It defines "first responder" to include firefighters, law enforcement officers, detention center/prison staff, and emergency care providers, requiring a diagnosis per the latest DSM-5 manual that links PTSD directly to work duties. The bill amended existing laws to allow PTSD claims under workers' compensation, subject to standard procedural requirements. However, this bill was vetoed by the Governor on June 9, 2025, so it did not become law.
SB 136 amends Montana's criminal code (Section 45-2-211, MCA) to state that a patient's consent to physician aid in dying is not a defense to a homicide charge against the physician. The bill defines "physician aid in dying" as a physician prescribing a lethal medication for the patient to self-administer, excluding standard comfort care or withholding life-sustaining treatment. This directly affects physicians who provide such aid, making their actions prosecutable as homicide if consent is claimed as a defense. The law takes effect July 1, 2025, and does not impact existing practices of comfort care or end-of-life treatment under Montana law.
SB 474 would have expanded school immunization exemptions in Montana to include religious exemptions and a new "personal medical informed consent" exemption requiring only a notarized statement. This new exemption would allow students to decline vaccines after consulting a healthcare provider (without needing a provider's signature), distinct from the existing medical exemption requiring a healthcare provider's written statement. The bill also amended school immunization laws (20-5-405 and 49-2-312) to prevent schools from being sued for injuries related to exempt students and to block overly burdensome exemption forms. The bill died in committee on May 23, 2025, and never became law.
SB 164 amends Montana's endangering the welfare of children law to prohibit specific medical treatments for children under 16. The bill bans surgical procedures, puberty blockers, and hormone therapies (like estrogen or testosterone) when used to alter a child's appearance or affirm a gender identity inconsistent with their biological sex. Violating this prohibition is classified as a felony, carrying up to five years in prison and a $10,000 fine, with harsher penalties if the child suffers serious injury. The law would take effect on January 1, 2026, directly affecting medical providers, caregivers, and children under 16 who might receive these treatments.
HB 185 directs the Department of Public Health and Human Services (DPHHS) to implement continuous eligibility for children under six years old in the Healthy Montana Kids plan. This means eligible children would remain enrolled in the program until their sixth birthday, regardless of changes in family income or other circumstances that might otherwise make them ineligible. DPHHS is required to apply for the necessary federal waivers and state plan amendments by July 1, 2025, and implement the continuous eligibility within six months of federal approval. The bill aims to provide consistent health coverage for young children enrolled in Medicaid and the Children's Health Insurance Program.
HB 947 requires most individual health insurance policies in Montana to cover continuous glucose monitors (CGMs) and their supplies for people diagnosed with type I or type II diabetes when medically necessary, as prescribed by a healthcare provider. The bill prohibits insurers from denying coverage based on diabetes severity or insulin dependence, and bans special deductibles or limits specifically for CGMs - though standard deductibles may still apply. This affects diabetes patients covered by individual disability, health, or membership insurance plans (excluding Medicare supplements, hospital indemnity, or long-term care policies). The law aims to ensure consistent access to these critical blood sugar monitoring tools without discriminatory coverage barriers.
HB 274 sought to establish a medical respite care program in Montana for homeless individuals who are eligible for Medicaid. This program would have provided short-term housing in residential facilities with supportive medical services for those recovering from illness or injury but not requiring hospitalization. Services would have included treatment plan monitoring, medication management, immunizations, discharge planning, and transportation for medical appointments. The bill directed the Department of Public Health and Human Services to seek federal approval for the program and to report annually on its costs and the number of individuals served.
HB 609 sought to establish the criminal offense of "abortion trafficking." It would prohibit any person from purposely or knowingly transporting an unborn child from Montana, either within or outside the state, to obtain an abortion that is illegal under Montana law. Individuals convicted of this offense could face fines up to $1,000, imprisonment for up to five years, or both. The bill also included a provision allowing penalties to be imposed against the mother of an unborn child for violating this specific trafficking offense, which is an exception to general prohibitions against penalizing women for abortion-related acts.
HB 783 aimed to revise health insurance laws by requiring coverage for specific conditions and treatments. It would have mandated individual health insurance policies to cover glucagon-like peptide-1 receptor agonists and treatments for polycystic ovary syndrome when medically necessary, including for diagnoses of diabetes or class 3 obesity. While allowing standard cost-sharing and cost containment measures, the bill prohibited special limitations on glucagon-like peptide-1 receptor agonists. Additionally, it sought to add other mandatory coverages, such as fertility preservation services and therapies for Down syndrome, to state group health plans. The bill would have affected individuals with these conditions and those covered by applicable health insurance policies in the state.